1 - 10 out of 20Page size: 10
  1. 2023

  2. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer

    Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

    ten Hoorn, S., Waasdorp, C., van Oijen, M. G. H., Damhofer, H., Trinh, A., Zhao, L., Smits, L. J. H., Bootsma, S., van Pelt, G. W., Mesker, W. E., Mol, L., Goey, K. K. H., Koopman, M., Medema, J. P., Tuynman, J. B., Zlobec, I., Punt, C. J. A., Vermeulen, L. & Bijlsma, M. F., 1 Dec 2022, In: BMC cancer. 22, 1, 394.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer

    Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T. F. J., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P., Koster, J., Zwijnenburg, D. A., Spek, C. A., Klomp, J. P. G., Oubrie, A., Hooijer, G. K. J., Meijer, S. L., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J., Oyarce, C., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 15 Nov 2022, In: Cell Reports Medicine. 3, 11, 100802.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. 2021

  7. Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer

    Dutch Pancreatic Cancer Group, Dec 2021, In: HPB. 23, 12, p. 1886-1896 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer

    Lodestijn, S. C., Miedema, D. M., Lenos, K. J., Nijman, L. E., Belt, S. C., el Makrini, K., Lecca, M. C., Waasdorp, C., van den Bosch, T., Bijlsma, M. F. & Vermeulen, L., 19 Oct 2021, In: Cell reports. 37, 3, 109852.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Erratum: Stromal-derived interleukin 6 drives epithelialto- mesenchymal transition and therapy resistance in esophageal adenocarcinoma (Proc. Natl. Acad. Sci. U.S.A. (2019) 116 (2237-2242) DOI: 10.1073/pnas.1820459116)

    Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., Krishnadath, K. K., Punt, C. J. A., van Berge Henegouwen, M. I., Gisbertz, S. S., van Delden, O. M., Hulshof, M. C. C. M., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 14 Sep 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 37, e2113728118.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  10. Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

    Dammeijer, F., de Gooijer, C. J., van Gulijk, M., Lukkes, M., Klaase, L., Lievense, L. A., Waasdorp, C., Jebbink, M., Bootsma, G. P., Stigt, J. A., Biesma, B., Kaijen-Lambers, M. E. H., Mankor, J., Vroman, H., Cornelissen, R., Baas, P., van der Noort, V., Burgers, J. A. & Aerts, J. G., Feb 2021, In: EBioMedicine. 64, 103160.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. 2020

  12. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

    Dijk, F., Veenstra, V. L., Soer, E. C., Dings, M. P. G., Zhao, L., Halfwerk, J. B., Hooijer, G. K., Damhofer, H., Marzano, M., Steins, A., Waasdorp, C., Busch, O. R., Besselink, M. G., Tol, J. A., Welling, L., van Rijssen, L. B., Klompmaker, S., Wilmink, H. W., van Laarhoven, H. W., Medema, J. P., & 7 othersVermeulen, L., van Hooff, S. R., Koster, J., Verheij, J., van de Vijver, M. J., Wang, X. & Bijlsma, M. F., 1 Dec 2020, In: Scientific reports. 10, 1, p. 337 337.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation

    Tekin, C., Aberson, H. L., Waasdorp, C., Hooijer, G. K. J., de Boer, O. J., Dijk, F., Bijlsma, M. F. & Spek, C. A., Dec 2020, In: Cellular oncology. 43, 6, p. 1161-1174 14 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  14. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1

    Steins, A., van Mackelenbergh, M. G., van der Zalm, A. P., Klaassen, R., Serrels, B., Goris, S. G., Kocher, H. M., Waasdorp, C., de Jong, J. H., Tekin, C., Besselink, M. G., Busch, O. R., van de Vijver, M. J., Verheij, J., Dijk, F., van Tienhoven, G., Wilmink, J. W., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 6 May 2020, In: EMBO reports. 21, 5, e48780.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 104210